Leading Sites

Category

University of Chicago & University of Illinois at Chicago Receive $2m as Part of RADx Initiative Focusing on COVID-19 in Underserved Communities

Funded by a $2 million award from the National institutes of Health RADx-UP program, part of the Rapid Acceleration of Diagnostics (RADx) initiative, University of Chicago Medicine and University of Illinois at Chicago (UIC) researchers are investigating the effects...

Montefiore & Einstein Open COVID-19 Vaccine Unit to Ensure Underrepresented Included in COVID-19 Vaccine Trials

Preeminent New York City healthcare institutions, ones with global brand recognition and influence, introduce a new COVID-19 vaccine unit, established to support the enrollment of participants in clinical trials to test efficacy of the vaccines against SARS-CoV-2, the...

OneOncology Partners with Genentech to Bring Personalized Cancer Research to Patients at Community Oncology Sites

The cancer research as a care option movement gains considerable momentum in the United States with the recent formation of a partnership between OneOncology, the national partnership of independent oncology practices, and Genentech, a member of the Roche Group (SIX:...

Kentucky Healthcare Systems Gear up for Large Phase 3 ENSEMBLE Study Investigating J&J’s COVID-19 Single Dose Vaccine Candidate

Healthcare providers in Kentucky have been selected for a major global Phase 3 COVID-19 vaccine clinical trial, including University of Kentucky (UK) Hospital, Baptist Health Lexington and Norton Healthcare in Louisville serve as trial site locations for the massive...

Gem of an Principal Investigator & Trial Site Organization Contributes to the Successful Moderna COVID-19 Vaccine Study: World Meet Quality of Life Medical Research Center

Trial Site organizations make clinical trials successful. The principal investigators, co-and sub-investigators, coordinators, regulatory personnel, and not to mention other health and support staff at the research center, are a fundamental point of interest for...

Southeast Nebraska Cancer Center Joints Elite NCI Cancer Networks to Offer State-of-Art Clinical Trials to Nebraskan Cancer Patients

The Southeast Nebraska Cancer Center (SNCC) brings the clinical research as a care option movement to Lincoln, Nebraska, and more generally the eastern regions of the state. By offering local patients with advanced oncologic and hematologic diagnoses comprehensive,...

Velocity Clinical Research Strategic Move to Diversify Patient Enrollment Options: Southern California eStudySite Acquisition

Private equity-backed site organization roll-up Velocity Clinical Research purchased eStudySite, contributing two trial site locations in San Diego, California to its North American site portfolio, now totaling 14 sites. Located in both La Mesa and Chula Vista,...

UNC’s Baric Lab Key Contributor to Now Approved Remdesivir (Veklury®): Top Experts in Coronaviruses

Remdesivir has become a blockbuster drug in short time thanks in part to a pandemic-driven ACTIV-1 clinical trial and subsequent U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) in May followed by permanent approval on October 22. Any...

University of Kansas Medical Center Becomes Hub for American Lung Association Research COVID-19-based Studies

The American Lung Association’s research arm known as Airways Clinical Research Centers (ACRC) now supports a study investigating optimal therapies and treatments for those with preexisting respiratory conditions who also become infected with SARS-CoV-2, the virus...

Atrium Health Helps Pave Path Toward Clinical Research as a Care Option Targeting COVID-19 with Three New Clinical Trials Offering Outpatient Hope

Atrium Health, formerly the Carolinas HealthCare System, has been active on multiple fronts battling COVID-19. The nonprofit network of over 40 hospitals and over 900 care locations in North Carolina, South Carolina, and Georgia have also emerged as a leading player...

University of Chicago Medicine Prepares Innovative Personalized Diabetes Care Clinical Trial with $5m from NIDDK

Researchers at the University of Chicago Medicine are launching a four-year research trial to test the effects of two evidenced-based interventions for personalized diabetes care for older adults, thanks to a new $5 million grant provided by the National Institute of...

Karmanos Cancer Institute Launches Diversity & Inclusion Committee & Participates in the Detroit Renaissance

With the move to precision medicine, especially in oncology, the inclusion of diverse populations in research and development can be a matter of life and death. Thought of another way, with ethnic minorities and others considered underrepresented experiencing cancer...

Hackensack University Medical Center Offers Clinical Trial to Investigate Nerve Recovery Post Robotic Prostatectomy for Prostate Cancer

Hackensack Meridian Hackensack University Medical Center’s Department of Urology is among the first in the nation to embrace bioregenerative medicine as a new way to promote nerve regeneration and a faster return to normal erectile and urinary function after...

Pin It on Pinterest